Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71 GBX | +1.43% | +4.41% | +42.00% |
03-26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
03-26 | BATM Advanced ink USD2.3 million orders | AN |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+42.00% | 92.52M | - | ||
+12.29% | 87.1B | B | ||
+9.07% | 69.19B | B | ||
-9.11% | 41.54B | C- | ||
+5.78% | 21.29B | C+ | ||
-18.32% | 11.82B | A- | ||
-9.90% | 9.9B | C | ||
+8.34% | 8.77B | C+ | ||
-24.84% | 7.67B | B+ | ||
+5.51% | 4.79B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TRU Stock
- Ratings TruFin plc